What's the Future of Microbiome Therapies in CDI, Cancer?
Preventive treatments for C difficile recurrence are in phase 3 trials. Oncologists are also investigating microbiome-based differences in treatment response.
Stay updated with breaking news from C Diff Infection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Preventive treatments for C difficile recurrence are in phase 3 trials. Oncologists are also investigating microbiome-based differences in treatment response.
Aerosolized hydrogen peroxide is a new tool in fighting C. difficile in healthcare settings.
There's mixed news from Pfizer on results from the CLOVER trial of their candidate vaccine for preventing C diff infection.
RESTORE-UC trial results contradict positive results seen in previous trials despite using highly standardized "superdonor" samples.
The detection of a marked increase in unrecognized strains of C difficile suggests a 'pressing need' to understand mechanisms.